|Articles|January 4, 2018

ZS acquires Nielsen BASES tools for pharma market forecasting

Adds to company’s Forecasting Practice

ZS, the Evanston, IL-based sales-effectiveness consultancy, is adding to its pre-launch forecasting services with Nielsen BASES, a combination of “forecasting tools [and] normative databases,” according to ZS. BASES is best know among marketers of consumer packaged goods, and Nielsen retains the assets not directed at pharmaceutical marketing and foreasting.

ZS’ forecasting business is incorporated into a range of commercialization activities, including market access analyses, product development strategy and resource planning and development. With BASES, the company says that it can provide “a consolidated offering that covers both long-term and short-term forecasts [with] comprehensive benchmarks of pre-launch pharmaceutical prescription products.”


Related to this article

CVS Pharmacy Sign at Storefront Entrance | © Mark Roger Bailey - stock.adobe.com 557616813
In this week’s Pharma Pulse, CVS Health plans to separate into two public companies, Bayer weighs what MFN pricing could mean for its launch strategies and an ACTO survey finds most life sciences leaders see no clear industry standard for responsible AI.